Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19

Background: We aimed to analyze clinical characteristics and find potential factors to predict poor prognosis in patients with coronavirus disease 2019 (COVID-19). Methods: We analyzed the clinical characteristics and laboratory tests of COVID-19 patients and detected SARS-CoV-2 RNA in urine sedimen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lu Zhang, Maoqing Tian, Yuan Song, Wei Liang, Xiaogang Li, Yongqing Tong, Huiming Wang
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2b6712f718834667892be5af95f5bfb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2b6712f718834667892be5af95f5bfb7
record_format dspace
spelling oai:doaj.org-article:2b6712f718834667892be5af95f5bfb72021-11-25T17:21:32ZUrinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-1910.3390/diagnostics111120892075-4418https://doaj.org/article/2b6712f718834667892be5af95f5bfb72021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2089https://doaj.org/toc/2075-4418Background: We aimed to analyze clinical characteristics and find potential factors to predict poor prognosis in patients with coronavirus disease 2019 (COVID-19). Methods: We analyzed the clinical characteristics and laboratory tests of COVID-19 patients and detected SARS-CoV-2 RNA in urine sediments collected from 53 COVID-19 patients enrolled in Renmin Hospital of Wuhan University from 31 January 2020 to 18 February 2020 with qRT-PCR analysis. Then, we classified those patients based on clinical conditions (severe or non-severe syndrome) and urinary SARS-CoV-2 RNA (U<sub>RNA</sub><sup>−</sup> or U<sub>RNA</sub><sup>+</sup>). Results: We found that COVID-19 patients with severe syndrome (severe patients) showed significantly higher positive rate (11 of 23, 47.8%) of urinary SARS-CoV-2 RNA than non-severe patients (4 of 30, 13.3%, <i>p</i> = 0.006). U<sub>RNA</sub><sup>+</sup> patients or severe U<sub>RNA</sub><sup>+</sup> subgroup exhibited higher prevalence of inflammation and immune discord, cardiovascular diseases, liver damage and renal dysfunction, and higher risk of death than U<sub>RNA</sub><sup>−</sup> patients. To understand the potential mechanisms underlying the viral urine shedding, we performed renal histopathological analysis on postmortems of patients with COVID-19 and found severe renal vascular endothelium lesion characterized by an increase of the expression of thrombomodulin and von Willebrand factor, markers to assess the endothelium dysfunction. We proposed a theoretical and mathematic model to depict the potential factors that determine the urine shedding of SARS-CoV-2. Conclusions: This study indicated that urinary SARS-CoV-2 RNA detected in urine specimens can be used to predict the progression and prognosis of COVID-19 severity.Lu ZhangMaoqing TianYuan SongWei LiangXiaogang LiYongqing TongHuiming WangMDPI AGarticleCOVID-19SARS-CoV-2endotheliumrenal pathologyindicatorMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2089, p 2089 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
SARS-CoV-2
endothelium
renal pathology
indicator
Medicine (General)
R5-920
spellingShingle COVID-19
SARS-CoV-2
endothelium
renal pathology
indicator
Medicine (General)
R5-920
Lu Zhang
Maoqing Tian
Yuan Song
Wei Liang
Xiaogang Li
Yongqing Tong
Huiming Wang
Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19
description Background: We aimed to analyze clinical characteristics and find potential factors to predict poor prognosis in patients with coronavirus disease 2019 (COVID-19). Methods: We analyzed the clinical characteristics and laboratory tests of COVID-19 patients and detected SARS-CoV-2 RNA in urine sediments collected from 53 COVID-19 patients enrolled in Renmin Hospital of Wuhan University from 31 January 2020 to 18 February 2020 with qRT-PCR analysis. Then, we classified those patients based on clinical conditions (severe or non-severe syndrome) and urinary SARS-CoV-2 RNA (U<sub>RNA</sub><sup>−</sup> or U<sub>RNA</sub><sup>+</sup>). Results: We found that COVID-19 patients with severe syndrome (severe patients) showed significantly higher positive rate (11 of 23, 47.8%) of urinary SARS-CoV-2 RNA than non-severe patients (4 of 30, 13.3%, <i>p</i> = 0.006). U<sub>RNA</sub><sup>+</sup> patients or severe U<sub>RNA</sub><sup>+</sup> subgroup exhibited higher prevalence of inflammation and immune discord, cardiovascular diseases, liver damage and renal dysfunction, and higher risk of death than U<sub>RNA</sub><sup>−</sup> patients. To understand the potential mechanisms underlying the viral urine shedding, we performed renal histopathological analysis on postmortems of patients with COVID-19 and found severe renal vascular endothelium lesion characterized by an increase of the expression of thrombomodulin and von Willebrand factor, markers to assess the endothelium dysfunction. We proposed a theoretical and mathematic model to depict the potential factors that determine the urine shedding of SARS-CoV-2. Conclusions: This study indicated that urinary SARS-CoV-2 RNA detected in urine specimens can be used to predict the progression and prognosis of COVID-19 severity.
format article
author Lu Zhang
Maoqing Tian
Yuan Song
Wei Liang
Xiaogang Li
Yongqing Tong
Huiming Wang
author_facet Lu Zhang
Maoqing Tian
Yuan Song
Wei Liang
Xiaogang Li
Yongqing Tong
Huiming Wang
author_sort Lu Zhang
title Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19
title_short Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19
title_full Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19
title_fullStr Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19
title_full_unstemmed Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19
title_sort urinary sars-cov-2 rna is an indicator for the progression and prognosis of covid-19
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2b6712f718834667892be5af95f5bfb7
work_keys_str_mv AT luzhang urinarysarscov2rnaisanindicatorfortheprogressionandprognosisofcovid19
AT maoqingtian urinarysarscov2rnaisanindicatorfortheprogressionandprognosisofcovid19
AT yuansong urinarysarscov2rnaisanindicatorfortheprogressionandprognosisofcovid19
AT weiliang urinarysarscov2rnaisanindicatorfortheprogressionandprognosisofcovid19
AT xiaogangli urinarysarscov2rnaisanindicatorfortheprogressionandprognosisofcovid19
AT yongqingtong urinarysarscov2rnaisanindicatorfortheprogressionandprognosisofcovid19
AT huimingwang urinarysarscov2rnaisanindicatorfortheprogressionandprognosisofcovid19
_version_ 1718412458551410688